How Krystexxa Works: Turning Uric Acid Into Something Your Body Can Actually Clear

Gout pain does not wait for a good time to show up. It can turn a normal Tuesday into a night spent unable to put a sheet over your foot. If you’ve recently been prescribed Krystexxa, you may be wondering, how Krystexxa works?

Here is the quick answer. Krystexxa (pegloticase) works by supplying an enzyme your body does not naturally make. That enzyme breaks down uric acid into allantoin, a substance your kidneys can flush out easily. For patients with chronic gout that has stopped responding to standard treatment, that shift can mean fewer flares and real relief.

The rest of this will walk you through what is actually happening in your bloodstream. It also covers what a Krystexxa infusion looks like at Infusion Specialists right here in Idaho Falls.

Why Uric Acid Builds Up in the First Place

Your body makes uric acid every day. It is a normal byproduct of breaking down purines, which come from certain foods and from your own cells.

Most people clear uric acid without any trouble. But in chronic gout, uric acid production outpaces the body’s ability to remove it. Over months and years, that excess uric acid forms sharp, needle-like crystals in joints and soft tissue. Those crystals are what trigger the swelling, redness, and severe pain of a gout flare.

Standard gout medications work by either slowing uric acid production or helping the kidneys excrete more of it. For most patients, that is enough. For patients with severe, treatment-resistant gout, it is not.

The Enzyme Your Body Is Missing

Here is the strange part. Most mammals have an enzyme called uricase that breaks uric acid down automatically. Humans do not. A mutation many generations back turned off the gene that produces it.

Pegloticase is built to fill that gap. It is a lab-made version of uricase, and it does the job your own body cannot. It catalyzes a reaction that converts uric acid into allantoin. Allantoin dissolves far more easily than uric acid, so your kidneys can clear it out without much resistance.

This is why Krystexxa works differently than pills that slow uric acid production. It actively breaks down the uric acid that is already causing problems.

What Pegylation Actually Does

The “peg” in pegloticase stands for polyethylene glycol, a coating attached to the uricase enzyme. That coating serves two jobs.

First, it helps the enzyme stay active in the bloodstream longer, instead of breaking down within minutes. Second, it lowers the odds of your immune system attacking the enzyme as a foreign invader. Without that coating, the treatment would clear your system too fast to work.

What a Krystexxa Infusion Actually Looks Like

Krystexxa is given as an IV infusion, not a pill or injection you take at home. Each session runs about 3 hours, and treatment is typically scheduled every 2 weeks.

Many patients receive methotrexate alongside Krystexxa. Adding it can improve how well the treatment works. It also lowers the chance of an infusion reaction. Your prescribing physician will decide whether that combination fits your case.

Every session happens in a private suite with a recliner, wifi, and snacks within reach. Nurses, like Angie and Jim, monitor patients closely throughout the 3-hour window. Infusion reactions are one of the more common risks with this treatment, so close monitoring matters. You can review the full Krystexxa treatment details, including side effects and what to expect on your first visit.

Patients often mention how much a comfortable setting matters during a treatment that takes this long. See what other patients say by reading reviews on Google.

Signs the Treatment Is Working

Your care team will check uric acid levels before each infusion. A level under 6 mg/dL is generally the target. Many patients on Krystexxa drop well below that within the first few weeks.

Flares can actually increase during the first 3 months as old uric acid crystals dissolve and shift. That sounds discouraging, but it is a known part of the process, not a sign that treatment is failing. Most patients see flare frequency drop significantly after that initial adjustment period.

Safety and Monitoring

Before starting Krystexxa, your provider will test for G6PD deficiency, a genetic condition that makes this treatment unsafe. This step is not optional and protects you from a serious reaction.

During each infusion, our clinical staff watches for signs of an allergic response, including flushing, wheezing, or swelling. That is one of the main reasons Krystexxa is given in a clinical setting instead of at home.

Your doctor will prescribe an oral medication called methotrexate. It’s important that you take this exactly as prescribed for 4 weeks before starting Krystexxa and continue taking it the whole time you’re on Krystexxa. This medication helps prevent your body from forming antibodies against Krystexxa. 

You will also have to get your uric acid levels checked 24-48 hours before each scheduled infusion. This helps your infusion clinic ensure Krystexxa is doing its job and is safe to give again.

Already Have a Krystexxa Prescription?

Chronic gout that will not respond to standard treatment deserves a real conversation about options. That conversation starts with your primary care provider or rheumatologist. Only they can diagnose your gout and decide whether Krystexxa is the right prescription for you.

Once you and your doctor have made that call, contact Infusion Specialists to schedule your infusions. We’ll get you set up in a private suite built for comfort.